Document Detail

Variability of In Vivo Fluid Dose Distribution in Mouse Airways Is Visualized by High-Speed Synchrotron X-Ray Imaging.
MedLine Citation:
PMID:  23298238     Owner:  NLM     Status:  Publisher    
Abstract Background: The manner in which fluid instillations into mouse nose and lung distribute through the airways is poorly understood. Many agents are delivered in this way for testing as therapeutics, or as challenges designed to establish infections or create systemic drug delivery effects. These agents are delivered into mouse airways with little knowledge of the manner in which doses move through the airways, how long they reside in each region, and where the instilled materials eventually reach. Methods: Synchrotron phase-contrast X-ray imaging (PCXI) was used to elucidate the primary controlling characteristics of mouse airway fluid dosing. High-speed image acquisition was used to track the movement of a range of bolus doses of an iodine-based contrast fluid through the nose (n=15) and lungs (n=10) of live anesthetized mice. For the lung studies, the mice were ventilated and paralyzed to control animal movement. Post-experiment image processing was used to visualize the fluid movement. Results: The maximum dose that could be retained in only the anterior nose was ∼7.5 μL (20 g mouse), and a range of dynamic dose behaviors was documented after delivery. In the lung, the use of mechanical ventilation in combination with a paralytic agent prevented confounding artifactual movement, improving visualization of fluid progression through the airways. In the lung, optimized image analysis using the high image capture rate revealed the presence of respiratory pauses that could not be visualized at slower acquisition rates. The variability in the outcome of identical dose deliveries in different animals indicates that uniform lung distribution cannot be expected to occur with tracheal fluid delivery. Conclusions: With adequate imaging rate and fluid dose parameters, this study shows the utility of synchrotron PCXI for determining the post-delivery behavior and fate of fluid doses such as those used in in vivo gene transfer or pharmaceutical studies.
Martin Donnelley; Kaye S Morgan; Karen K W Siu; David W Parsons
Related Documents :
12852548 - Use of bang polymer gel for dose measurements in a 68 mev proton beam.
19935958 - Particle image identification and correlation analysis in microscopic holographic parti...
18952038 - Quantitation of green fluorescent protein using a gel-based imaging method.
2103518 - Image analysis of the chromatin organization in the nuclear domains of freeze fractured...
17769268 - Satellite-image-derived velocity field of an antarctic ice stream.
22949058 - Visually lossless encoding for jpeg2000.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-8
Journal Detail:
Title:  Journal of aerosol medicine and pulmonary drug delivery     Volume:  -     ISSN:  1941-2703     ISO Abbreviation:  J Aerosol Med Pulm Drug Deliv     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101475057     Medline TA:  J Aerosol Med Pulm Drug Deliv     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Respiratory and Sleep Medicine, Women's and Children's Health Network , Adelaide, Australia .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Three novel germ-line VHL mutations in Hungarian von Hippel-Lindau patients, including a nonsense mu...
Next Document:  Controlled copper ion release from phosphate-based glasses improves human umbilical vein endothelial...